Lanean...
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Amyloid light chain (AL) amyloidosis is a systemic disease characterised by the aggregation of misfolded immunoglobulin light chain (LC), predominantly in the heart and kidneys, causing organ failure. If untreated, the median survival of patients with cardiac AL amyloidosis is 6 months from the onse...
Gorde:
| Argitaratua izan da: | Heart |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566095/ https://ncbi.nlm.nih.gov/pubmed/28456755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2016-310704 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|